Cargando…
MEK Is a Potential Indirect Target in Subtypes of Head and Neck Cancers
The poor prognosis of head-and-neck squamous cell carcinoma (HNSCC) is partly due to the lack of reliable prognostic and predictive markers. The Ras/Raf/MEK/ERK signaling pathway is often activated by overexpressed epidermal growth factor receptor (EGFR) and stimulates the progression of HNSCCs. Our...
Autores principales: | Gurbi, Bianka, Brauswetter, Diána, Pénzes, Kinga, Varga, Attila, Krenács, Tibor, Dános, Kornél, Birtalan, Ede, Tamás, László, Csala, Miklós |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917750/ https://www.ncbi.nlm.nih.gov/pubmed/36769112 http://dx.doi.org/10.3390/ijms24032782 |
Ejemplares similares
-
The Potential Impact of Connexin 43 Expression on Bcl-2 Protein Level and Taxane Sensitivity in Head and Neck Cancers–In Vitro Studies
por: Gurbi, Bianka, et al.
Publicado: (2019) -
Molecular subtype specific efficacy of MEK inhibitors in pancreatic cancers
por: Brauswetter, Diána, et al.
Publicado: (2017) -
Suitability of GnRH Receptors for Targeted Photodynamic Therapy in Head and Neck Cancers
por: Pethő, Lilla, et al.
Publicado: (2019) -
Protein Kinase D3 (PKD3) Requires Hsp90 for Stability and Promotion of Prostate Cancer Cell Migration
por: Varga, Attila, et al.
Publicado: (2023) -
Novel Erlotinib–Chalcone Hybrids Diminish Resistance in Head and Neck Cancer by Inducing Multiple Cell Death Mechanisms
por: Murányi, József, et al.
Publicado: (2023)